skip to Main Content
NEWS
[Edaily] C&R Research Selected For Government Task Related To Standardization Of Clinical Trial Data

[Edaily] C&R Research selected for government task related to standardization of clinical trial data

C&R Research (359090) (CEO Moon-Tae Yoon), Korea's largest clinical trial consignment agency, is carrying out 'data standardization and application tasks…

Read more →
[Sedaily] “Re-pursuing The Acquisition Of A Clinical Trial Consignment Agency… Taking The Lead To Decentralized Clinical Trial.”

[Sedaily] “Re-pursuing the acquisition of a Clinical Trial consignment agency… Taking the lead to Decentralized Clinical Trial.”

“For a domestic blockbuster new drug to be created, domestic contract research organizations (CROs) must first secure global-level capabilities. This…

Read more →
[Yakup] C&R Research “The Answer To Success In Developing Advanced Biopharmaceuticals Is Cooperation And Communication.”

[Yakup] C&R Research “The answer to success in developing advanced biopharmaceuticals is cooperation and communication.”

Expert opinions were presented that close cooperation between various fields of expertise, including companies, regulatory agencies, and CROs (drug development…

Read more →
[Edaily] C&R Research Signs Joint Curriculum Development MOU With SAS

[Edaily] C&R Research signs joint curriculum development MOU with SAS

C&R Research (359090) (CEO Moon-Tae Yoon), Korea's largest clinical trial consignment agency, and SAS Korea (CEO Seung-Woo Lee), a world-class…

Read more →
[Newsprime] C&R Research Received ‘highest Ever’ New Orders Last Year, Expected To Turn Profitable

[Newsprime] C&R Research received ‘highest ever’ new orders last year, expected to turn profitable

‘Stocks’ is considered a hot keyword for investors who are unable to find suitable investments, including the MZ generation.  …

Read more →
Back To Top